title: Is universal pediatric lipid screening justified?
authors.affiliation: Harvard Medical School/Harvard Pilgrim Health Care Institute, Department of Population Medicine, 133 Brookline Ave, Sixth Floor, Boston, MA 02215, USA. matthew_gillman@hms.harvard.edu
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Gillman
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Daniels
mesh_terms: D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D002648:Child; D008078:Cholesterol, LDL / Q000097:blood; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008019:Life Style; D008403:Mass Screening / Q000592:standards*; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D008078:Cholesterol, LDL